Clinical Trial Update: Longitudinal Study of Patients With Opioid-Induced Constipation

View source ↗

Summary

A longitudinal clinical trial on patients with opioid-induced constipation sponsored by AstraZeneca has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Constipation

Snippet

Sponsor: AstraZeneca | Conditions: Patients With Opioid Induced Constipation | Status: COMPLETED